Stories by Charles Ornstein

The second-year resident worries what will happen to his patients

In 2009, Congress asked for recommendations on what to do about information that falls outside the privacy law known as HIPAA. Health officials released their report, but offered no suggestions

New data released today will promote transparency and help patients know when docs receive money from product makers

GlaxoSmithKline, which makes Advair for asthma, Lovaza for high triglyceride levels and the diabetes drug Avandia, is under pressure facing all drug companies for greater transparency in payments to doctors, a provision of Obamacare